Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Advanced Training in Structural Heart Disease, Duke University School of Medicine 2017 - 2018
  • Interventional Cardiology Fellowship, Duke University School of Medicine 2016 - 2017
  • Cardiovascular Disease Fellowship, Duke University School of Medicine 2012 - 2016
  • Internal Medicine Residency, Brigham and Women's Hospital 2009 - 2012
  • M.D., Johns Hopkins University School of Medicine 2009
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Lopes, Renato D., Sergio Leonardi, Daniel M. Wojdyla, Amit N. Vora, Laine Thomas, Robert F. Storey, Dragos Vinereanu, et al. “Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.” Circulation 141, no. 9 (March 3, 2020): 781–83. https://doi.org/10.1161/CIRCULATIONAHA.119.044584.
       Full Text  Link to Item
    • Chung, Matthew J., Asvin M. Ganapathi, Amit N. Vora, Jacob N. Schroder, Todd L. Kiefer, and G Chad Hughes. “Valve-in-Ring Transcatheter Aortic Valve Replacement After Left Ventricular Assist Device Therapy.” Ann Thorac Surg 109, no. 3 (March 2020): e163–65. https://doi.org/10.1016/j.athoracsur.2019.06.094.
       Full Text  Link to Item
    • Vora, Amit N., John H. Alexander, Daniel M. Wojdyla, Ronald Aronson, Christopher B. Granger, Harald Darius, Stephan Windecker, et al. “Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.” Circulation 140, no. 23 (December 3, 2019): 1960–63. https://doi.org/10.1161/CIRCULATIONAHA.119.043754.
       Full Text  Link to Item
    • Siddique, Saima, Hemal Gada, Mubashir A. Mumtaz, and Amit N. Vora. “Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations.” Curr Cardiol Rep 21, no. 12 (November 28, 2019): 161. https://doi.org/10.1007/s11886-019-1250-5.
       Full Text  Link to Item
    • Vora, Amy, James A. de Lemos, Colby Ayers, Justin L. Grodin, and Ildiko Lingvay. “Association of Galectin-3 With Diabetes Mellitus in the Dallas Heart Study.” J Clin Endocrinol Metab 104, no. 10 (October 1, 2019): 4449–58. https://doi.org/10.1210/jc.2019-00398.
       Full Text  Link to Item
    • Fanaroff, Alexander C., Amit N. Vora, Anita Y. Chen, Robin Mathews, Jacob A. Udell, Matthew T. Roe, Laine E. Thomas, and Tracy Y. Wang. “Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data Registry.” Am Heart J 214 (August 2019): 184–93. https://doi.org/10.1016/j.ahj.2019.05.011.
       Full Text  Link to Item
    • Bhardwaj, Bhaskar, John A. Spertus, Kevin F. Kennedy, W Schuyler Jones, David Safley, Thomas T. Tsai, Herbert D. Aronow, et al. “Bleeding Complications in Lower-Extremity Peripheral Vascular Interventions: Insights From the NCDR PVI Registry.” Jacc Cardiovasc Interv 12, no. 12 (June 24, 2019): 1140–49. https://doi.org/10.1016/j.jcin.2019.03.012.
       Full Text  Link to Item
    • Lopes, Renato D., Gretchen Heizer, Ronald Aronson, Amit N. Vora, Tyler Massaro, Roxana Mehran, Shaun G. Goodman, et al. “Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.” N Engl J Med 380, no. 16 (April 18, 2019): 1509–24. https://doi.org/10.1056/NEJMoa1817083.
       Full Text  Link to Item
    • Sherwood, Matthew W., and Amit N. Vora. “Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.” Curr Cardiol Rep 20, no. 12 (October 11, 2018): 130. https://doi.org/10.1007/s11886-018-1073-9.
       Full Text  Link to Item
    • Sherwood, Matthew W., Sreekanth Vemulapalli, John Kevin Harrison, David Dai, Amit N. Vora, Michael J. Mack, David R. Holmes, et al. “Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry.” Am Heart J 204 (October 2018): 9–16. https://doi.org/10.1016/j.ahj.2018.06.006.
       Full Text  Link to Item
    • Vora, Amit N., Dadi Dai, Roland Matsuoka, J Kevin Harrison, G Chad Hughes, Matthew W. Sherwood, Jonathan P. Piccini, et al. “Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.” Jacc Cardiovasc Interv 11, no. 17 (September 10, 2018): 1746–56. https://doi.org/10.1016/j.jcin.2018.05.042.
       Full Text  Link to Item
    • Eikelboom, John W., Stuart J. Connolly, Jackie Bosch, Gilles R. Dagenais, Robert G. Hart, Olga Shestakovska, Rafael Diaz, et al. “Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.” N Engl J Med 377, no. 14 (October 5, 2017): 1319–30. https://doi.org/10.1056/NEJMoa1709118.
       Full Text  Link to Item

  • Conference Papers

    • Gada, Hemal, Amit Vora, Daniel O’Hair, Cara Brigman, Loren Wagner, Chris Rogers, Logan Brigman, and Navjot Kohli. “TCT-743 Comparison of Patient and Clinical Factors Within Echocardiogram Reports to Predict Disparity in Care of Patients With Severe Aortic Stenosis.” In Journal of the American College of Cardiology, 74:B729–B729. Elsevier BV, 2019. https://doi.org/10.1016/j.jacc.2019.08.879.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.